Interpreting findings of studies on a non-steroidal MRA in T2DM and CKD

Click here for the CME course on ReachMD

10' education - Nov. 9, 2021 - Prof. George Bakris, MD (Chicago, IL, USA), prof. Betram Pitt, MD (Ann Arbor, MI, USA) and prof. Rajiv Agarwal, MD (Indianapolis, IN, USA)

Video navigation menu

Overview of the FIGARO-DKD trial 0:26
Impact of results on clinical practice 4:52
Overview of the FIDELITY analysis 7:31
Discussion 10:11

Educational information

This video was developed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.

Faculty

George L. Bakris, Professor of Medicine and Director of Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA.

Bertram Pitt is Professor of Internal Medicine at the University of Michigan School of Medicine in Ann Arbor, MI, USA.

Rajiv Agarwal, MD, MBBS, FASN is Professor of Medicine at Indiana University School of Medicine at Indianapolis, IN, USA.

Disclosures

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.

Funding

Funding for this educational program was provided by and independent educational grant from Bayer AG.

Click here for the CME course on ReachMD

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.